Citation Impact
Citing Papers
Adjuvant Whole-Brain Radiotherapy Versus Observation After Radiosurgery or Surgical Resection of One to Three Cerebral Metastases: Results of the EORTC 22952-26001 Study
2010 Standout
Pazopanib in Locally Advanced or Metastatic Renal Cell Carcinoma: Results of a Randomized Phase III Trial
2010 Standout
Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations
2013 Standout
Efficacy and Safety of Trastuzumab as a Single Agent in First-Line Treatment of HER2-Overexpressing Metastatic Breast Cancer
2002 Standout
Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer
2000 Standout
Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial
2008 Standout
Enduring impact of communication skills training: results of a 12-month follow-up
2003
Screening for Depression in Women with Metastatic Breast Cancer: A Comparison of the Beck Depression Inventory Short form and the Hospital Anxiety and Depression Scale
2004
Report of two protocol planned interim analyses in a randomised multicentre phase III study comparing capecitabine with fluorouracil and oxaliplatin with cisplatin in patients with advanced oesophagogastric cancer receiving ECF
2005
Multinational Study of the Efficacy and Safety of Humanized Anti-HER2 Monoclonal Antibody in Women Who Have HER2-Overexpressing Metastatic Breast Cancer That Has Progressed After Chemotherapy for Metastatic Disease
1999 Standout
The Effects of Major Depression and Phobia on Stage at Diagnosis of Breast Cancer
1999
Screening for depression in head and neck cancer
2003
Acceptability of common screening methods used to detect distress and related mood disorders—preferences of cancer specialists and non‐specialists
2007
Development of an Impact Thermometer for use in combination with the Distress Thermometer as a brief screening tool for adjustment disorders and/or major depression in cancer patients
2005
Psychiatric Disorders Following First Breast Cancer Recurrence: Prevalence, Associated Factors and Relationship to Quality of Life
2005
Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer
1998
The EORTC Core Quality of Life questionnaire (QLQ-C30): validity and reliability when analysed with patients treated with palliative radiotherapy
1995
Dacomitinib versus gefitinib as first-line treatment for patients with EGFR-mutation-positive non-small-cell lung cancer (ARCHER 1050): a randomised, open-label, phase 3 trial
2017
Prevalence of Depression in Patients With Cancer
2004 Standout
Prevalence, predictive factors, and screening for psychologic distress in patients with newly diagnosed head and neck cancer
2000
Time until definitive quality of life score deterioration as a means of longitudinal analysis for treatment trials in patients with metastatic pancreatic adenocarcinoma
2010
Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal Cancer
2006 Standout
Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicentre, randomised controlled trial
2005 Standout
Phase II study of weekly docetaxel in symptomatic androgen-independent prostate cancer
2001
Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer
1998
A view on drug resistance in cancer
2019 StandoutNature
Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer
2007
Breaking bad news: structured training for family medicine residents
2002
Quality of life of Danish women: Population-based norms for the EORTC QLQ-C30
1997
Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial
2014 Standout
Medroxyprogesterone, interferon alfa‐2a, interleukin 2, or combination of both cytokines in patients with metastatic renal carcinoma of intermediate prognosis
2007
The Swedish SF-36 Health Survey—I. Evaluation of data quality, scaling assumptions, reliability and construct validity across general populations in Sweden
1995
Thermal hyperalgesia as a marker of oxaliplatin neurotoxicity: A prospective quantified sensory assessment study
2009
An Analysis of the Validity of the Hospital Anxiety and Depression Scale as a Screening Tool in Patients with Advanced Metastatic Cancer
2001
Depression in Patients With Lung Cancer: Prevalence and Risk Factors Derived From Quality-of-Life Data
2000
Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
2009 Standout
Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer.
1997
The interpretation of scores from the EORTC quality of life questionnaire QLQ-C30
1996
Test/retest study of the European Organization for Research and Treatment of Cancer Core Quality-of-Life Questionnaire.
1995
The biology and management of non-small cell lung cancer
2018 StandoutNature
Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies
2011 Standout
CHOP versus MACOP-B in aggressive lymphoma - a Nordic Lymphoma Group randomised trial
1999
First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer
2014 Standout
Quality of life research within the EORTC—the EORTC QLQ-C30
2002
Difficulties in screening for adjustment disorder, Part I: Use of existing screening instruments in cancer patients undergoing bone marrow transplantation
2004
Patient self-reported and clinician-rated quality of life in head and neck cancer patients: a cross-sectional study
1995
A prospective multicentre study in Sweden and Norway of mental distress and psychiatric morbidity in head and neck cancer patients
1999
A Randomized Trial of Chemoradiotherapy and Chemotherapy after Resection of Pancreatic Cancer
2004 Standout
Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points.
1996 Standout
Screening for anxiety and depression in cancer patients: the effects of disease and treatment
1994
The performance status scale for head and neck cancer patients and the functional assessment of cancer therapy-head and neck scale: A study of utility and validity
1996
Quality of life after palliative radiotherapy in patients with hormone‐resistant prostate cancer: single institution experience
1994
Psychological Sequelae of Cancer Diagnosis
1997
The role of the 5-HT3 antagonists ondansetron and dolasetron in the control of delayed onset nausea and vomiting in patients receiving moderately emetogenic chemotherapy
1997
Physicians' attitudes to and problems with truth-telling to cancer patients
2000
Afatinib versus cisplatin plus gemcitabine for first-line treatment of Asian patients with advanced non-small-cell lung cancer harbouring EGFR mutations (LUX-Lung 6): an open-label, randomised phase 3 trial
2014 Standout
A phase II study of gemcitabine in platinum pre-treated patients with advanced epithelial ovarian cancer
1998
Effect of schedule and maintenance on the antiemetic efficacy of ondansetron combined with dexamethasone in acute and delayed nausea and emesis in patients receiving moderately emetogenic chemotherapy: a phase III trial by the National Cancer Institute of Canada Clinical Trials Group.
1994
The SF‐36 in an Australian sample: validating a new, generic health status measure
1995
The development of a training model to improve health professionals' skills, self-efficacy and outcome expectancies when communicating with cancer patients
1997
German translation and psychometric testing of the SF-36 Health Survey: Preliminary results from the IQOLA project
1995
Interpreting the significance of changes in health-related quality-of-life scores.
1998 Standout
Affective syndromes and their screening in cancer patients with early and stable disease: Italian ICD-10 data and performance of the Distress Thermometer from the Southern European Psycho-Oncology Study (SEPOS)
2008
Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors
2011 Standout
Docetaxel versus active symptom control for refractory oesophagogastric adenocarcinoma (COUGAR-02): an open-label, phase 3 randomised controlled trial
2013
Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma
2007 Standout
Early Palliative Care for Patients with Metastatic Non–Small-Cell Lung Cancer
2010 Standout
CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma
2002 Standout
An international validation study of the EORTC brain cancer module (EORTC QLQ-BN20) for assessing health-related quality of life and symptoms in brain cancer patients
2010
Interventions to prevent and reduce physician burnout: a systematic review and meta-analysis
2016 Standout
Evaluation of screening instruments for depression and anxiety in breast cancer survivors
2009
Screening for Psychological Distress in Japanese Cancer Patients
1998
Chemotherapy versus supportive care in advanced non-small cell lung cancer: improved survival without detriment to quality of life
2004
Whole brain irradiation following surgery or radiosurgery for solitary brain metastases: Mature results of a prematurely closed randomized Trans-Tasman Radiation Oncology Group trial (TROG 98.05)
2006
Increasing oncologists' skills in eliciting and responding to emotional cues: evaluation of a communication skills training program
2007
Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma
2014 Standout
Psychiatric morbidity and its screening in Turkish women with breast cancer: a comparison between the HADS and SCID tests
2007
Effectiveness of Specialized Palliative Care
2008
Modification of the EORTC QLQ-C30 (version 2.0) based on content validity and reliability testing in large samples of patients with cancer
1997
Communicating sad, bad, and difficult news in medicine
2004 Standout
Erlotinib in Previously Treated Non–Small-Cell Lung Cancer
2005 Standout
A validation study of the Hospital Anxiety and Depression Scale (HADS) in different groups of Dutch subjects
1997 Standout
Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer
2004 Standout
Concise assessment for depression (CAD): A brief screening approach to depression in the medically ill
1996
Can mood disorder in women with breast cancer be identified preoperatively?
1995
Health-related quality of life in the general Norwegian population assessed by the European Organization for Research and Treatment of Cancer Core Quality-of-Life Questionnaire: the QLQ=C30 (+ 3).
1998
Screening for Anxiety and Depression in Women With Breast Cancer
1999
The European Organization for Research and treatment of cancer approach to quality of life assessment: guidelines for developing questionnaire modules
1993
What is a clinically meaningful change on the Functional Assessment of Cancer Therapy–Lung (FACT-L) Questionnaire?Results from Eastern Cooperative Oncology Group (ECOG) Study 5592
2002
The benefits of being present: Mindfulness and its role in psychological well-being.
2003 Standout
Screening for psychiatric morbidity in patients with advanced breast cancer: validation of two self-report questionnaires
1991
Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial
2001
Depression and Anxiety Disorders in Palliative Cancer Care
2007
Amitriptyline in the Treatment of Chemotherapy-Induced Neuropathic Symptoms
2007
The EORTC QLQ-LC13: a modular supplement to the EORTC core quality of life questionnaire (QLQ-C30) for use in lung cancer clinical trials
1994
Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse
2001
Chemotherapy-Induced Nausea and Vomiting
2008 Standout
Causal indicators in quality of life research
1997
Psychometric properties and responsiveness of the EORTC Quality of Life Questionnaire (QLQ-C30) in patients with breast, ovarian and lung cancer
1994
Determinants of postchemotherapy nausea and vomiting in patients with cancer. Quality of Life and Symptom Control Committees of the National Cancer Institute of Canada Clinical Trials Group.
1997
Screening for adjustment disorders and major depression in otolaryngology patients using the Hospital Anxiety and Depression Scale
1999
Quality of life changes in COPD patients treated with salmeterol.
1997
The validity of the Hospital Anxiety and Depression Scale
2002 Standout
Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study
2017 Standout
Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument.
1997 Standout
Evaluating Translations of Health Status Questionnaires: Methods From the IQOLA Project
1995
Communication Skills Training for Japanese Oncologists on How to Break Bad News
2003
Cellular and Molecular Mechanisms of Pain
2009 StandoutNobel
SF-36 Health Survey Update
2000 Standout
Afatinib versus placebo for patients with advanced, metastatic non-small-cell lung cancer after failure of erlotinib, gefitinib, or both, and one or two lines of chemotherapy (LUX-Lung 1): a phase 2b/3 randomised trial
2012
Hospital Anxiety and Depression Scale (HAD): some psychometric data for a Swedish sample
1997
Uptake of psychosocial referrals in an outpatient cancer setting: improving service accessibility via the referral process
2002
A confirmatory factor analysis of the Hospital Anxiety and Depression scale: Comparing empirically and theoretically derived structures
2000
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
2010 Standout
Depression among cancer patients
1996
Medical students' attitudes towards breaking bad news: an empirical test of the World Health Organization model
2001
Multilingual translation of the Functional Assessment of Cancer Therapy (FACT) quality of life measurement system
1996
Diagnostic validity of the Hospital Anxiety and Depression Scale (HADS) in cancer and palliative settings: A meta-analysis
2010
Reliability and validity of the functional assessment of cancer therapy—lung (FACT-L) quality of life instrument
1995
Psychiatric disorders and associated factors in cancer
2001
Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial
2000 Standout
Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2
2001 Standout
Predicting mood disorders in breast cancer patients
2001
Capecitabine and Oxaliplatin for Advanced Esophagogastric Cancer
2008 Standout
Symptom indicator of severity of depression in cancer patients: a comparison of the DSM-IV criteria with alternative diagnostic criteria
2009
Detecting psychological distress in cancer patients: validity of the Italian version of the Hospital Anxiety and Depression Scale
1999
Comparison of Four Chemotherapy Regimens for Advanced Non–Small-Cell Lung Cancer
2002 Standout
Performance of the Hospital Anxiety and Depression Scale as a screening tool for major depressive disorder in cancer patients
2007
Factor analysis, causal indicators and quality of life
1997
Poor efficacy of the hospital anxiety and depression scale in the diagnosis of major depressive disorder in both medical and psychiatric patients
1994
A systematic review of the clinical effectiveness of first-line chemotherapy for adult patients with locally advanced or metastatic non-small cell lung cancer
2015
Quality of life in patients treated for head and neck cancer: A follow-up study 7 to 11 years after radiotherapy
1994
Are we using appropriate self-report questionnaires for detecting anxiety and depression in women with early breast cancer?
1999
Anticipatory nausea and vomiting in the era of 5-HT 3 antiemetics
1998
Longitudinal assessment of quality of life in laryngeal cancer patients
1996
Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer
1997
The development and psychometric validation of a brain cancer quality-of-life questionnaire for use in combination with general cancer-specific questionnaires
1996
Final results of a randomised trial comparing ‘Tomudex’® (raltitrexed) with 5-fluorouracil plus leucovorin in advanced colorectal cancer
1996
The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: The QLQ-CIPN20
2005
Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
2016 Standout
A phase III trial of pemetrexed plus gemcitabine versus gemcitabine in patients with unresectable or metastatic pancreatic cancer
2005
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
The impact of generalized malignant melanoma on quality of life evaluated by the EORTC questionnaire technique
1993
Preventing occupational stress in healthcare workers
2015
Assessment of Quality of Life in the Supportive Care Setting of the Big Lung Trial in Non–Small-Cell Lung Cancer
2005
Health-Related Quality of Life in Men With Metastatic Prostate Cancer Treated With Prednisone Alone or Mitoxantrone and Prednisone
1999
Pretreatment Quality of Life and Functional Status Assessment Significantly Predict Survival of Elderly Patients With Advanced Non—Small-Cell Lung Cancer Receiving Chemotherapy: A Prognostic Analysis of the Multicenter Italian Lung Cancer in the Elderly Study
2005
Phase III Study of Docetaxel and Cisplatin Plus Fluorouracil Compared With Cisplatin and Fluorouracil As First-Line Therapy for Advanced Gastric Cancer: A Report of the V325 Study Group
2006 Standout
The Factor Structure and Factor Stability of the Hospital Anxiety and Depression Scale in Patients with Cancer
1991
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
2011 Standout
A psychometric evaluation of the Hospital Anxiety and Depression Scale in coronary care patients following acute myocardial infarction
2000
Screening for psychiatric illness in the palliative care inpatient setting: a comparison between the Hospital Anxiety and Depression Scale and the General Health Questionnaire-12
1999
Screening for mental disorders in cancer patients – discriminant validity of HADS and GHQ‐12 assessed by standardized clinical interview
2001
Diagnostic Efficiency of the Hospital Anxiety and Depression Scale in Women with Early Stage Breast Cancer
2002
Mitomycin, Ifosfamide, and Cisplatin in Unresectable Non–Small-Cell Lung Cancer: Effects on Survival and Quality of Life
1999
Symptom Control and Quality of Life in LUX-Lung 3: A Phase III Study of Afatinib or Cisplatin/Pemetrexed in Patients With Advanced Lung Adenocarcinoma With EGFR Mutations
2013
Development and validation of the Functional Assessment of Cancer Therapy-Kidney Symptom Index (FKSI).
2006
A Brief Measure for Assessing Generalized Anxiety Disorder
2006 Standout
Self-Reported Quality of Life of Individual Cancer Patients: Concordance of Results With Disease Course and Medical Records
2001
The SF-36 Health Survey: Development and Use in Mental Health Research and the IQOLA Project
1994
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
2014 Standout
Benefit of Temozolomide Compared to Procarbazine in Treatment of Glioblastoma Multiforme at First Relapse: Effect on Neurological Functioning, Performance Status, and Health Related Quality of Life
2005
Quality of Life in Palliative Cancer Care: Results From a Cluster Randomized Trial
2001
Prospective, Longitudinal Quality‐of‐Life Study of Patients With Head and Neck Cancer: A Feasibility Study Including the EORTC QLQ‐C30
1997
Health-Related Quality of Life in Patients Treated With Temozolomide Versus Procarbazine for Recurrent Glioblastoma Multiforme
2000
Recurrent Epithelial Ovarian Carcinoma: A Randomized Phase III Study of Pegylated Liposomal Doxorubicin Versus Topotecan
2001 Standout
Pooled Results From 38 Analyses of the Accuracy of Distress Thermometer and Other Ultra-Short Methods of Detecting Cancer-Related Mood Disorders
2007
Irinotecan Plus Oxaliplatin and Leucovorin-Modulated Fluorouracil in Advanced Pancreatic Cancer—A Groupe Tumeurs Digestives of the Fédération Nationale des Centres de Lutte Contre le Cancer Study
2005
Sensitivity and specificity of a two-question screening tool for depression in a specialist palliative care unit
2007
Quality of Life in Head and Neck Cancer Patients: Validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-H&N35
1999 Standout
A Randomized, Double-Blinded, Placebo-Controlled Phase II Trial of Recombinant Human Leukemia Inhibitory Factor (rhuLIF, Emfilermin, AM424) to Prevent Chemotherapy-Induced Peripheral Neuropathy
2005
Communication skills training in oncology. Description and preliminary outcomes of workshops on breaking bad news and managing patient reactions to illness.
1999
Efficacy and Safety of Trastuzumab as a Single Agent in First-Line Treatment of HER2-Overexpressing Metastatic Breast Cancer
2002 Standout
Anxiety Disorders in Cancer Patients: Their Nature, Associations, and Relation to Quality of Life
2002
Utility of the Hospital Anxiety and Depression Scale in patients with end-stage renal disease on continuous ambulatory peritoneal dialysis
1999
Multivariate Prognostic Factor Analysis in Locally Advanced and Metastatic Esophago-Gastric Cancer—Pooled Analysis From Three Multicenter, Randomized, Controlled Trials Using Individual Patient Data
2004
Effect of breaking bad news on patients' perceptions of doctors
2002
Quality of Life Supersedes the Classic Prognosticators for Long-Term Survival in Locally Advanced Non–Small-Cell Lung Cancer: An Analysis of RTOG 9801
2009
Depressive disorders in an outpatient oncology setting: prevalence, assessment, and management
1998
Flutamide Versus Prednisone in Patients With Prostate Cancer Symptomatically Progressing After Androgen-Ablative Therapy: A Phase III Study of the European Organization for Research and Treatment of Cancer Genitourinary Group
2001
International experiences with the Hospital Anxiety and Depression Scale-A review of validation data and clinical results
1997 Standout
Communication skills training in oncology
1999
The structure of the hospital anxiety and depression scale (HAD): An appraisal with normal, psychiatric and medical patient subjects
1997
Amitriptyline in the prevention of chemotherapy-induced neuropathic symptoms.
2009
Phase III Randomized Comparison of Gemcitabine Versus Gemcitabine Plus Capecitabine in Patients With Advanced Pancreatic Cancer
2009
Prospective Randomized Trial Comparing Mitomycin, Cisplatin, and Protracted Venous-Infusion Fluorouracil (PVI 5-FU) With Epirubicin, Cisplatin, and PVI 5-FU in Advanced Esophagogastric Cancer
2002
Works of Darius Razavi being referenced
Anxiety, depression and psychiatric disorders in cancer patients: Assessment and risk factors
1986
Effects of a 105 hours psychological training program on attitudes, communication skills and occupational stress in oncology: a randomised study
2004
Does training increase the use of more emotionally laden words by nurses when talking with cancer patients? A randomised study
2002
Communication skills and psychological training in oncology
1997
International quality of life assessment (IQOLA) project
1992
Common psychiatric disorders in cancer patients
1994
Depression in palliative care: a pragmatic report from the Expert Working Group of the European Association for Palliative Care
2001
Insight on Variables Leading to Burnout in Cancer Physicians
2010
Screening for Adjustment Disorders and Major Depressive Disorders in Cancer In-Patients
1990
Prevention of adjustment disorders and anticipatory nausea secondary to adjuvant chemotherapy: a double-blind, placebo-controlled study assessing the usefulness of alprazolam.
1993
Communication skills training in cancer care: where are we and where are we going?
2005
Screening for psychiatric disorders in a lymphoma out-patient population
1992
Cancer care—A stress for health professionals
1988
Immediate effectiveness of brief psychological training for health professionals dealing with terminally ill cancer patients: A controlled study
1988
Psychosocial correlates of oestrogen and progesterone receptors in breast cancer
1990
The effects of a 24-h psychological training program on attitudes, communication skills and occupational stress in oncology: a randomised study
1993
Factors that influence physicians' detection of distress in patients with cancer
2005
Common psychiatric disorders in cancer patients
1994
Development of a European Organization for Research and Treatment of Cancer (Eortc) Questionnaire Module to be Used in Quality of Life Assessments in Head and Neck Cancer Patients
1994
Brief psychological training for health care professionals dealing with cancer patients: A one-year assessment
1991
The effect of fluoxetine on anxiety and depression symptoms in cancer patients
1996
Translating health. The International Quality of Life Assessment (IQOLA) project
1994
[Improving doctor's communication skills in oncology: review and future perspectives].
2001
The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology
1993 Standout
Efficacy of a Communication and Stress Management Training on Medical Residents’ Self-efficacy, Stress to Communicate and Burnout
2010